Phio Pharmaceuticals Corp (PHIO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Phio Pharmaceuticals Corp  (NASDAQ: PHIO)


Phio Pharmaceuticals's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Phio Pharmaceuticals's ROI in the second quarter of 2026?
Phio Pharmaceuticals Corp recorded a cumulative net loss of $-13 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -84.96%.

Within the Healthcare sector 591 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2240 to 3946.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 90.25 % 120.77 % 174.34 % 66.99 % 31.31 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 14 16 20 10 10
Return On Investment (TTM) -84.96 % -77.34 % -66.59 % -86.38 % -88.75 %
PHIO's Overall Ranking # 3946 # 2240 # 2549 # 3396 # 3545
Seq. Investment Change TTM 7.45 % 8.21 % 41.88 % 15.32 % 24.68 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -13 -11 -9 -8 -7

PHIO Company Profile >> Back to PHIO Roi Comparisons >> See Annual PHIO Return On Investment



Return On Investment PHIO's Ranking
Within: No.
Industry # 266
Sector # 592
Overall # 3946

Return On Investment Statistics
High Average Low
-48.13 %
-122.79 %
-411.48 %
(Jun 30 2021)   (Sep 30 2018)







Financial Statements
Phio Pharmaceuticals's II. Quarter Investments $ 14 Millions PHIO's Balance sheet
Phio Pharmaceuticals's II. Quarter Income $ -4 Millions Quarterly PHIO's Income Statement
PHIO's Income by Division See PHIO's Income by Division


PHIO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 21 5 8 11 22
Y / Y Investment Growth 354.94 % -38.9 % -28.92 % -50.8 % 63.2 %
Net Income in Millions -9 -7 -11 -11 -13
Y / Y Net Income Growth - - - - -
Annual Return On Investment -40.48 % -151.39 % -140.05 % -105.56 % -60.12 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PHIO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PHIO's Competitors
Subscribers only: Roi for Phio Pharmaceuticals's Suppliers
Subscribers only: Return On Investment for PHIO's Customers

Other Ratios
PHIO's Roa PHIO's Inventory Turnover Ratio PHIO's Growth Rates PHIO's Dividend Statistics
PHIO's Profitability Ratios PHIO's Asset Turnover Ratio PHIO's Dividend Growth
PHIO's Roe PHIO's Valuation Ratios PHIO's Financial Strength Ratios PHIO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T20:02:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.